Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Ранг среди акций #26685
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Цена акции
$3.49
Последняя синхронизация: 2023-12-19
Рыночная капитализация
$38.68M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Neoleukin Therapeutics, Inc. (NLTX)

Категория

История дроблений акций Neoleukin Therapeutics, Inc. (NLTX)
Акции Neoleukin Therapeutics, Inc. (символ: NLTX) прошли через 0 дроблений.
Последнее дробление произошло Aug 20, 2026.
Одна акция NLTX, купленная до Aug 20, 2026, сейчас соответствует 0 акциям NLTX.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
0 -
DE
0 -
DE
0 -
JP
0 -
CH
5 x119
IN